Journal Home
Search for

Volume 102, Issue 10, Pages 979-982 (October 2008)


View previous. 6 of 19 View next.

Viewpoint: management of human rabies

Henry WildeaCorresponding Author Informationemail address, Thiravat Hemachudhaa, Alan C. Jacksonb

Received 11 February 2008; received in revised form 3 April 2008; accepted 3 April 2008.

Summary 

Rabies remains a serious public health problem in many developing countries. A case in the West received media attention with the recovery of an American teenager who had not received rabies post-exposure prophylaxis. This case confirmed that rabies is not an invariably fatal disease. Review of the literature revealed only two survivors with good neurological status in nearly 40 years. Both had neutralizing antibodies in cerebrospinal fluid at or shortly after presentation, but the usual diagnostic tests for rabies were negative, a rather unique finding. It is highly probable that these two children managed to mount an unusually effective early immune response to the infection that contributed to, or was responsible for, recovery. Curative efforts for human rabies using critical care resources should especially target patients who show early neutralizing antibody. More basic research is needed to develop effective therapies for human rabies.

a Faculty of Medicine, Division of Research and Department of Medicine, Chulalongkorn University Hospital, Bangkok 10330, Thailand

b Departments of Internal Medicine (Neurology) and Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

Corresponding Author InformationCorresponding author.

PII: S0035-9203(08)00154-5

doi:10.1016/j.trstmh.2008.04.008


View previous. 6 of 19 View next.